Some skincare products may still contain microplastics despite a European Union restriction on the materials in cosmetics [1].

The persistence of these particles raises significant questions about the efficacy of environmental regulations and the potential long-term risks to human health and ecosystems.

Environmental lawyer Hélène Duguy and environmental chemist Iseult Lynch said these concerns during a recent episode of Euronews Tech Talks. The discussion focused on the gap between legislation and the actual composition of products currently available to consumers.

In 2023, the EU restricted the use of microplastics in cosmetics [1]. This move was intended to curb the flow of synthetic polymer particles into the water supply and the food chain. However, experts said that certain products may still harbor these substances, either through loopholes in the definition of microplastics or slow industry transitions.

Microplastics are tiny plastic fragments that do not biodegrade. Once they enter the environment, they can be ingested by aquatic life and eventually enter human systems. The guests on the program explored how these particles interact with the skin and whether they can penetrate the biological barrier to cause internal harm.

Determining exactly which products remain contaminated is a challenge for consumers. Because microplastics are often invisible and listed under complex chemical names, identifying them requires professional laboratory analysis. The experts said that current labeling may not be sufficient to protect the public from exposure.

Industry leaders continue to seek alternatives to synthetic polymers, but the transition is uneven across the market. The discussion highlighted the need for stricter enforcement and clearer definitions to ensure that the 2023 restriction [1] achieves its environmental goals.

“Some skincare products may still contain microplastics despite a European Union restriction.”

The continued presence of microplastics in the EU market suggests a lag between policy enactment and industrial compliance. This gap indicates that regulatory bans alone may be insufficient without rigorous testing and transparent ingredient labeling, as the environmental and health risks of synthetic polymers persist despite legal prohibitions.